-
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
July 13, 2026 20:35 ET | Source: Mesoblast Limited NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has achieved its target of at least 300 patients treated in the MSB-DR004 pivotal Phase 3 randomized controlled trial of rexlemestrocel-L…
-
Kavalan Hits 1,000 Gold Medal-Milestone: Unveils Most-Awarded Whisky
From Taiwan to the World, Kavalan Marks a New Chapter in World Whisky History TAIPEI, June 11, 2026 /PRNewswire/ — Kavalan Whisky’s best kept secret is being uncovered as the Taiwanese distiller celebrates its 1,000th Gold Medal, two decades after the first drops of new make spirit were first distilled in Taiwan. Its “Most Awarded…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
